Chemical hazard prediction and hypothesis testing using quantitative adverse outcome pathways.


Journal

ALTEX
ISSN: 1868-8551
Titre abrégé: ALTEX
Pays: Germany
ID NLM: 100953980

Informations de publication

Date de publication:
2019
Historique:
received: 24 08 2018
accepted: 01 10 2018
entrez: 18 10 2018
pubmed: 18 10 2018
medline: 1 5 2019
Statut: ppublish

Résumé

Current efforts in chemical safety are focused on utilizing human in vitro or alternative animal data in biological pathway context. However, it remains unclear how biological pathways, and toxicology data developed in that context, can be used to quantitatively facilitate decision-making.  The objective of this work is to determine if hypothesis testing using Adverse Outcome Pathways (AOPs) can provide quantitative chemical hazard predictions.  Current methods for predicting hazards of chemicals in a biological pathway context were extensively reviewed, specific case studies examined and computational modeling used to demonstrate quantitative hazard prediction based on an AOP. Since AOPs are chemically agnostic, we propose that AOPs function as hypotheses for how specific chemicals may cause adverse effects via specific pathways. Three broad approaches were identified for testing the hypothesis with AOPs, semi-quantitative weight of evidence, probabilistic, and mechanistic modeling. We then demonstrate how these approaches could be used to test hypotheses using high throughput in vitro data and alternative animal data. Finally, we discuss standards in development and documentation that would facilitate use in a regulatory context. We conclude that quantitative AOPs provide a flexible hypothesis framework for predicting chemical hazards. It accommodates a wide range of approaches that are useful at many stages and build upon one another to become increasingly quantitative.

Identifiants

pubmed: 30332685
doi: 10.14573/altex.1808241
doi:

Substances chimiques

Hazardous Substances 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

91-102

Auteurs

Edward J Perkins (EJ)

US Army Engineer Research and Development Center, Vicksburg, MS, USA.

Kalyan Gayen (K)

Department of Chemical Engineering, National Institute of Technology Agartala, Barjala, Jirania, West Tripura, Tripura, India.

Jason E Shoemaker (JE)

Department of Chemical and Petroleum Engineering, Swanson School of Engineering, University of Pittsburgh, PA, USA.

Philipp Antczak (P)

University of Liverpool, Liverpool, Merseyside, UK.

Lyle Burgoon (L)

US Army Engineer Research and Development Center, Vicksburg, MS, USA.

Francesco Falciani (F)

University of Liverpool, Liverpool, Merseyside, UK.

Steve Gutsell (S)

Unilever, Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, UK.

Geoff Hodges (G)

Unilever, Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, UK.

Aude Kienzler (A)

JRC Institute for Health and Consumer Protection, Ispra, Italy.

Dries Knapen (D)

University of Antwerp, Zebrafishlab, Wilrijk, Belgium.

Mary McBride (M)

Agilent Technologies, Washington, DC, USA.

Catherine Willett (C)

The Humane Society of the United States, Washington, DC, USA.

Francis J Doyle (FJ)

Harvard John A. Paulson School of Engineering & Applied Sciences, Cambridge, MA, USA.

Natàlia Garcia-Reyero (N)

US Army Engineer Research and Development Center, Vicksburg, MS, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH